1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. New Jersey >
  6. Agennix AG Acquires GPC Biotech

M&A Deal Summary

Agennix AG Acquires GPC Biotech

On November 5, 2009, Agennix AG acquired life science company GPC Biotech

Acquisition Highlights
  • This is Agennix AG’s 1st transaction in the Life Science sector.
  • This is Agennix AG’s 1st transaction in the United States.
  • This is Agennix AG’s 1st transaction in New Jersey.

M&A Deal Summary
Date 2009-11-05
Target GPC Biotech
Sector Life Science
Buyer(s) Agennix AG
Deal Type Add-on Acquisition

Target

GPC Biotech

Princeton, New Jersey, United States
GPC Biotech is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Agennix AG

Heidelberg, Germany
Category Company
Sector Life Science
Employees52
DESCRIPTION

Agennix AG is a biopharmaceutical company. The Company’s clinical development programs include oral talactoferrin alfa; a topical gel form of talactoferrin and RGB-286638, a multi-targeted kinase inhibitor.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: New Jersey M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2009 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal